Stopping Beta-Blockers Abruptly: Rebound Hypertension & Withdrawal Risks

Danger: Rebound Phenomenon

Abrupt cessation of beta-blockers (especially after chronic use) can trigger a withdrawal syndrome due to upregulation of β-adrenergic receptors and loss of blockade.

Key Risks

  • Rebound Hypertension: BP surges above baseline; can precipitate hypertensive urgency/emergency.
  • Rebound Tachycardia/Arrhythmias: Unopposed sympathetic drive → palpitations, atrial fibrillation, ventricular ectopy.
  • Myocardial Ischemia/Infarction: Increased O₂ demand + coronary vasoconstriction → angina, MI (especially in CAD patients).
  • Stroke Risk: From BP surge.
  • Other Symptoms: Anxiety, tremor, sweating, headache, insomnia, muscle cramps.

Timeline

  • Onset: Within 12–48 hours (sooner with short-half-life agents like propranolol, metoprolol tartrate).
  • Peak: 2–5 days.
  • Resolution: 1–2 weeks (receptor downregulation).

Safe Discontinuation

  1. Never stop abruptly.
  2. Taper over 1–2+ weeks (longer for high doses, long duration, CAD). Example: reduce dose by 25–50% every 3–7 days.
  3. Switch to longer-acting agent (e.g., metoprolol succinate, bisoprolol) if on short-acting, then taper.
  4. Monitor BP/HR daily during taper.
  5. Coordinate with prescriber – they may substitute another antihypertensive class.
  6. Special Populations

    • Post-MI / Heart Failure: Beta-blockers are disease-modifying; discontinuation increases mortality. Change only under cardiologist guidance.
    • Thyrotoxicosis: Abrupt stop → thyroid storm risk.
    • Pheochromocytoma: Must have alpha-blockade established before beta-blockade; never stop alpha first.

Drug Addiction - Related Articles